|
|
|
|
| LEADER |
01621nam a22003015i 4500 |
| 001 |
978-3-642-74617-8 |
| 005 |
20191025031844.0 |
| 007 |
cr nn 008mamaa |
| 008 |
121227s1990 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642746178
|
| 024 |
7 |
|
|a 10.1007/978-3-642-74617-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 100 |
1 |
|
|a Schneeweiss, Adam.
|e author.
|
| 245 |
1 |
0 |
|a Cardiovascular Drug Therapy
|b Nitrate Therapy /
|c by Adam Schneeweiss.
|
| 250 |
|
|
|a 1st ed. 1990.
|
| 260 |
# |
# |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 1990.
|
| 300 |
|
|
|a XIII, 76 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Opening Remarks -- Presentation of the Sir Thomas Lauder Brunton Award for Outstanding Nitrate Research -- Origins of Symptoms in Heart Failure-Relevance in Evaluation of New Drugs -- Mononitrates in Congestive Heart Failure -- Are There Differences Between the Various Formulations of Nitrates in Heart Failure? -- Long-Term Nitrate Therapy — A Decade of Changing Concepts -- Nitrate Therapy in Angina Pectoris -- Mononitrates -- Transdermal Administration of Nitrates -- Nitrates in Angina Pectoris — Rationale of Use and Avoidance of Limitations -- Treatment of Congestive Heart Failure — Summary.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Cardiology.
|
| 650 |
1 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Cardiology.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-74617-8
|